Responding with Resilience - the Indian Pharma Sector
This article is part one of a series of three articles that
looks at the Supply Chain of the Pharmaceutical industry in the
context of the COVID-19 pandemic. Here, we examine the crisis, the
challenges that emerged, and the industry response in the short
term. Part 2 of the series will outline the 'Learnings from the
Crisis for Supply Chain Management', and part 3 will ideate on
the 'Supply Chain Management Strategy for the New
Normal'
The COVID-19 pandemic that has swept through the world this year
has caused unprecedented health and economic distress globally. To
curb the rapid spread of infection through their populations,
several countries imposed and continue to impose widespread
lockdowns. This has caused significant disruption in demand and
supply around the world.
